Literature DB >> 10374567

[Primary renal epithelioid angiosarcoma with transitional cell carcinoma in renal pelvis].

N Li1, W Li, Z Li.   

Abstract

To understand the clinical characteristics of primary renal epithelioid angiosarcoma. We used clinical pathology, immunohistochemistry and electron microscopy. Analysis and discussion about the case were combined with a review of the literature. We first report a female case of the left renal epithelioid angiosarcoma and concomitantly, transitional cell carcinoma developing from the renal pelvis at age 69. Epithelioid angiosarcoma showed positive results for FVIIIRA+, UEA, CD31, Cytokeratin and EMA. Weibel-Palade bodies were identified by electron microscopy. Primary renal epithelioid angiosarcoma was a rare clinical entity with a poor prognosis, which mimics epithelial tumor, both morphologically and immunohistochemically, and may be lead to misdiagnosis. The combined use of endothelial cell markers including FVIIIRA, CD31, UEA and electronmicroscopy can confirm the diagnosis of this neoplasm.

Entities:  

Mesh:

Year:  1997        PMID: 10374567

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  4 in total

1.  Primary epithelioid angiosarcoma of the male breast: report of a case.

Authors:  Ze-Sheng Wang; Na Zhan; Cheng-Long Xiong; Hui Li
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

2.  Primary Angiosarcoma of the Kidney: Case Report and Comprehensive Literature Review.

Authors:  Andrea Boni; Giovanni Cochetti; Angelo Sidoni; Guido Bellezza; Emanuele Lepri; Andrea De Giglio; Morena Turco; Jacopo Adolfo Rossi De Vermandois; Michele Del Zingaro; Roberto Cirocchi; Ettore Mearini
Journal:  Open Med (Wars)       Date:  2019-07-31

Review 3.  Primary vascular tumours of the kidney.

Authors:  Ayo O Omiyale
Journal:  World J Clin Oncol       Date:  2021-12-24

Review 4.  Clinicopathological features of primary angiosarcoma of the kidney: a review of 62 cases.

Authors:  Ayodeji Oluwarotimi Omiyale
Journal:  Transl Androl Urol       Date:  2015-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.